Is this you? Create Your Porfile
Avatar

Laak Antonius Ter

Bayer

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Laak Antonius Ter is active.

Explore More

Publication

Featured researches published by Laak Antonius Ter.

Archive | 2007

N-(1-hetarylpiperidin-4-yl)(het)arylamides as EP2 receptor modulators

Nico Bräuer; Bernd Buchmann; Marcus Koppitz; Laak Antonius Ter; Gernot Langer; Bernhard Lindenthal; Olaf Peters; Tim Wintermantel

Archive | 2007

N-(1-Phthalazin-1-ylpiperidin-4-yl)amides as EP2 receptor modulators

Nico Bräuer; Bernd Buchmann; Marcus Koppitz; Laak Antonius Ter; Gernot Langer; Bernhard Lindenthal; Olaf Peters; Tim Wintermantel

Archive | 2008

ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR

Bernd Buchmann; Nico Bräuer; Marcus Koppitz; Olaf Peters; Knut Eis; Laak Antonius Ter; Bernhard Lindenthal; Gernot Langer; Tim Wintermantel

Archive | 2012

Novel 2H-Indazoles as EP2 Receptor Antagonists

Nico Bräuer; Anne Mengel; Ulrike Röhn; Andrea Rotgeri; Bernd Buchmann; Bernhard Lindenthal; Laak Antonius Ter

Archive | 2005

3-amino-pyrazolo[3,4b]pyridines used as inhibitors of protein tyrosine kinases for treating angiogenic, hyperproliferative or neurodegenerative diseases

Wolfgang Schwede; Hermann Künzer; Laak Antonius Ter; Benjamin Bader; Roman Hillig; Ursula Mönning; Arndt Schmitz; Dieter Zopf

Archive | 2011

6,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicaments

Tim Wintermantel; Carsten Möller; Ulrich Bothe; Reinhard Nubbemeyer; Ludwig Zorn; Dirk Kosemund; Laak Antonius Ter; Rolf Bohlmann; Lars Wortmann; Donald Bierer

Archive | 2014

6,7-dihydro-5h-benzo[7]annulene derivatives, methods for the production thereof, pharmaceutical preparations that contain said 6,7-dihydro-5h-benzo[7]annulene derivatives, and use thereof to produce drugs

Tim Wintermantel; Carsten Moeller; Ulrich Bothe; Reinhard Nubbemeyer; Ludwig Zorn; Laak Antonius Ter; Rolf Bohlmann; Lars Wortmann

Archive | 2017

Dérivés de 5-(phényl)-1,2-dihydro-3h-3-benzazépine-3-carboxamide substitués en 2 utilisés en tant qu'inhibiteurs de brd4 pour le traitement du cancer

Stephan Siegel; Bernard Haendler; Rolf Bohlmann; Laak Antonius Ter; Amaury Ernesto Fernandez-Montalvan; Detlef Stöckigt

Archive | 2017

1h-benzo[de]isoquinoline-1,3(2h)-diones

Léa Bouché; Stephan Siegel; Bernard Haendler; Clara D. Christ; Laak Antonius Ter; Amaury Ernesto Fernandez-Montalvan; Detlef Stöckigt; Simon Holton

Archive | 2016

Phosphorous-and sulfur-substituted benzodiazepine derivatives

Stephan Siegel; Bernard Haendler; Laak Antonius Ter; Amaury Ernesto Fernandez-Montalvan; Detlef Stöckigt; Norbert Schmees

Explore More

Collaboration

Dive into the Laak Antonius Ter's collaboration.

Top Co-Authors
Avatar

Nico Bräuer

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Bernd Buchmann

Bayer

View shared research outputs
Top Co-Authors
Avatar

Bernhard Lindenthal

Bayer Schering Pharma AG

View shared research outputs
Top Co-Authors
Avatar

Gernot Langer

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Tim Wintermantel

Bayer

View shared research outputs
Top Co-Authors
Avatar

Olaf Peters

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Marcus Koppitz

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Amaury Ernesto Fernandez-Montalvan

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Detlef Stöckigt

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Bernard Haendler

Schering AG

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge